Related content

Recombinant Human Granulocyte-Macrophage Colony-stimulating Factor After Combined Chemotherapy in High-grade Non-Hodgkin's Lymphoma--a Randomised Pilot Study

By Bergmann L.   Karakas T.   Knuth A.   Lautenschlager G.   Mitrou P.S.   Hoelzer D.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2164-2168

Elsevier

Access to resources Recommend Favorite

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis

By Sprinzl G.M.   Galvan O.   de Vries A.   Ulmer H.   Gunkel A.R.   Lukas P.   Thumfart W.F.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2003-2009

Elsevier

Access to resources Recommend Favorite

Granulocyte-macrophage Colony-stimulating Factor Improves Immunological Parameters in Patients with Refractory Solid Tumours Receiving Second-line Chemotherapy: Correlation with Clinical Responses

By Baxevanis C.N.   Tsavaris N.B.   Papadhimitriou S.I.   Zarkadis I.K.   Papadopoulos N.G.   Bastounis E.A.   Papamichail M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1202-1208

Elsevier

Access to resources Recommend Favorite

Construction of a fusion expression plasmid containing the G250 gene and human granulocyte-macrophage colony stimulating factor and its significance in renal cell carcinoma

By Li Jun-Wu   Gong Jun-Yuan   Li Ke   Liu Yan   Ye Qiu-Ping   Liu Xin   Su Ze-Xuan  

Oncology Letters, Vol. 2, Iss. 2, 2011-03 ,pp. : 343-347

Spandidos Publications

Access to resources Recommend Favorite

Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor

By Kwasny W.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 3, 2000-10 ,pp. : 235-241

Springer Publishing Company

Access to resources Recommend Favorite